Cubist Systematic Strategies, LLC Akero Therapeutics, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 30,208 shares of AKRO stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,208Holding current value
$1.44 Million% of portfolio
0.01%Shares
20 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$352 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$328 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$288 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$267 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$250 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.22B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...